Takahiro Tsukida
Organon International
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takahiro Tsukida.
Bioorganic & Medicinal Chemistry Letters | 2003
Hideki Moriyama; Takahiro Tsukida; Yoshimasa Inoue; Hirosato Kondo; Kohichiro Yoshino; Shin-Ichiro Nishimura
In order to investigate structure-activity relationships of azasugar series toward metalloproteinases, we synthesized and evaluated several azasugar-based compounds. As a result, it was found that 4-phenoxybenzene derivative 3 having 2R,3R,4R,5S-configurations exhibited most potent inhibitory activities against matrix metalloproteinase-1, -3 and -9 and TACE.
Journal of Carbohydrate Chemistry | 1998
Masahiro Yoshida; Takao Kiyoi; Takahiro Tsukida; Hirosato Kondo
Abstract A stereocontrolled synthesis of Lex oligosaccharide derivatives using a facile one-pot, two-step glycosylation based on the “Armed-Disarmed” concept are described. The first coupling of phenyl O-(2,6-di-O-benzoyl-3,4-O-isopropylidene-β-D-galacto-pyranosyl)-(1→4)-2,6-di-O-benzoyl-1-thio-β-D-glucopyranoside (2) with phenyl 2,3,4-tri-O-benzyl-1-thio-β-L-fucopyranoside (3) using N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) gave the trisaccharide (8) which was subjected to the second condensation without purification with several acceptors such as ethyl 2,4,6-tri-O-benzyl-β-D-galactopyranoside (4), ethyl 2,6-di-O-benzoyl-β-D-galactopyranoside (5), ethyl O-(2,6-di-O-benzyl-β-D-galactopyranosyl)-(1→4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside (6), and ethyl O-(2,6-di-O-benzoyl-β-D-galactopyranosyl)-(1→4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside (7), to afford the desired Lex tetra- and pentasaccharides in good yields, respectively. 1. Dedicated to the memory of Professor Akira Hasegawa.
Bioorganic & Medicinal Chemistry Letters | 2003
Hideki Moriyama; Takahiro Tsukida; Yoshimasa Inoue; Hirosato Kondo; Kohichiro Yoshino; Shin-Ichiro Nishimura
In order to verify whether azasugar would be a useful scaffold for inhibitory activity against metalloproteinases, we synthesized some azasugar-based compounds. As a result, it is clarified that azasugar moiety could function as successful inhibitor of matrix metalloproteinase-1, -3 and -9 and TACE.
Bioorganic & Medicinal Chemistry Letters | 2001
Kyoko Fukunaga; Takahiro Tsukida; Hideki Moriyama; Hirosato Kondo
We have designed a series of simple rigid compounds (2) having a phenyl ring attached to three essential groups necessary for selectin binding, i.e., a fucose unit, a carboxylic acid, and the hydrophobic part. In this series of compound 2, 2a exhibited strong inhibitory activity in in vitro P-selectin mediated cell adhesion assay. The novel type of compound 2a would be a potential lead compound for selectin antagonist.
Journal of Medicinal Chemistry | 2004
Hideki Moriyama; Takahiro Tsukida; Yoshimasa Inoue; Kohichi Yokota; Kohichiro Yoshino; Hirosato Kondo; Nobuaki Miura; Shin-Ichiro Nishimura
Journal of Organic Chemistry | 1997
Takahiro Tsukida; Masahiro Yoshida; Kiriko Kurokawa; Yoshiyuki Nakai; Toshio Achiha; Takao Kiyoi; Hirosato Kondo
Archive | 1996
Takahiro Tsukida; Takao Kiyoi; Toshio Achiha; Hideki Moriyama; Kiriko Kurokawa; Hiroshi Ohmoto; Kenji Nakamura; Hirosato Kondo; Yukihisa Wada; Tadayuki Saito
Journal of Medicinal Chemistry | 1997
Takahiro Tsukida; Yasuyuki Hiramatsu; Hideki Tsujishita; Takao Kiyoi; Masahiro Yoshida; Kiriko Kurokawa; Hideki Moriyama; Hiroshi Ohmoto; Yukihisa Wada; Tadayuki Saito; Hirosata Kondo
Journal of Medicinal Chemistry | 1998
Yasuyuki Hiramatsu; Hideki Moriyama; Takao Kiyoi; Takahiro Tsukida; Yoshimasa Inoue; Hirosato Kondo
Journal of Medicinal Chemistry | 1998
Takahiro Tsukida; Hideki Moriyama; Kiriko Kurokawa; Toshio Achiha; Yoshimasa Inoue; Hirosato Kondo